PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
28.94%
Positive revenue growth while JHX is negative. John Neff might see a notable competitive edge here.
330.73%
Positive gross profit growth while JHX is negative. John Neff would see a clear operational edge over the competitor.
1860.29%
Positive EBIT growth while JHX is negative. John Neff might see a substantial edge in operational management.
1860.29%
Positive operating income growth while JHX is negative. John Neff might view this as a competitive edge in operations.
186.44%
Positive net income growth while JHX is negative. John Neff might see a big relative performance advantage.
186.96%
EPS growth of 186.96% while JHX is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
186.96%
Diluted EPS growth of 186.96% while JHX is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
0.32%
Share count expansion well above JHX's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.38%
Diluted share count expanding well above JHX's 0.09%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
323.43%
10Y revenue/share CAGR above 1.5x JHX's 12.36%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
193.02%
5Y revenue/share CAGR above 1.5x JHX's 12.36%. David Dodd would look for consistent product or market expansions fueling outperformance.
29.78%
3Y revenue/share CAGR above 1.5x JHX's 12.36%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
409.62%
Net income/share CAGR at 75-90% of JHX's 543.92%. Bill Ackman would press for strategic moves to boost long-term earnings.
2.65%
Below 50% of JHX's 543.92%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
45.54%
Below 50% of JHX's 543.92%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while JHX invests at 4.37%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.